regadenoson has been researched along with Cardiovascular Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babar, AK; Bui, L; DeGolovine, A; Gould, KL; Johnson, NP; Kitkungvan, D; Kumar, S; Madjid, M; Nacimbene, A; Patel, MB; Roby, AE; Vejpongsa, P | 1 |
| Borah, P; Deb, PK; Deka, S; Mailavaram, RP | 1 |
| Biederman, RW; Dishart, MK; Doyle, M; Fakhri, AA; Grant, SB; Nathan, S; Oliva, J; Poydence, J; Reddy, ST; Shah, M; Singh, A; Thai, NL; Tom, KB; Williams, RB; Yamrozik, JA | 1 |
| Ananthasubramaniam, K; Bhatti, S; Dhanalakota, S; Hakeem, A; Husain, Z; Jacobsen, G; Palani, G | 1 |
| Bengel, FM; Caobelli, F | 1 |
| Miller, EO; Schwartz, RG | 1 |
| Krishnamurthy, R; Moffett, B; Noel, CV | 1 |
1 review(s) available for regadenoson and Cardiovascular Diseases
| Article | Year |
|---|---|
P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future.
Topics: Adenosine; Asthma; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Ligands; Neoplasms; Parkinson Disease; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Receptors, Purinergic P1 | 2019 |
1 trial(s) available for regadenoson and Cardiovascular Diseases
| Article | Year |
|---|---|
Quantitative myocardial perfusion positron emission tomography and caffeine revisited with new insights on major adverse cardiovascular events and coronary flow capacity.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Aged; Caffeine; Cardiovascular Diseases; Coronary Circulation; Dipyridamole; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles | 2019 |
5 other study(ies) available for regadenoson and Cardiovascular Diseases
| Article | Year |
|---|---|
Exploratory use of cardiovascular magnetic resonance imaging in liver transplantation: a one-stop shop for preoperative cardiohepatic evaluation.
Topics: Adenosine; Adult; Cardiovascular Diseases; Contrast Media; Coronary Angiography; Dobutamine; Feasibility Studies; Female; Humans; Liver Diseases; Liver Transplantation; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Predictive Value of Tests; Preoperative Care; Purines; Pyrazoles | 2013 |
Prognostic value of regadenoson myocardial single-photon emission computed tomography in patients with different degrees of renal dysfunction.
Topics: Adenosine A2 Receptor Agonists; Aged; Biomarkers; Cardiovascular Diseases; Electrocardiography; Endpoint Determination; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Purines; Pyrazoles; Radiopharmaceuticals; Risk Factors; Survival Rate; Tomography, Emission-Computed, Single-Photon | 2014 |
Further evidence for the robustness of regadenoson stress myocardial perfusion SPECT: its predictive value for cardiac events in chronic renal failure.
Topics: Adenosine A2 Receptor Agonists; Cardiovascular Diseases; Female; Humans; Kidney Failure, Chronic; Male; Organophosphorus Compounds; Organotechnetium Compounds; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon | 2014 |
Cardiovascular risk assessment with regadenoson SPECT MPI in patients with end-stage renal disease is safe, effective, and well tolerated: Does it matter?
Topics: Cardiovascular Diseases; Humans; Kidney Failure, Chronic; Myocardial Perfusion Imaging; Purines; Pyrazoles; Renal Insufficiency, Chronic; Risk Assessment; Tomography, Emission-Computed, Single-Photon | 2017 |
Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson.
Topics: Adenosine A2 Receptor Agonists; Adolescent; Cardiovascular Diseases; Child; Exercise Test; Feasibility Studies; Female; Heart Defects, Congenital; Humans; Magnetic Resonance Imaging; Male; Pilot Projects; Purines; Pyrazoles; Young Adult | 2017 |